Clinical variability and probable founder effect in oculocutaneous albinism type 7.

MLA

Bataille, Pauline, et al. “Clinical Variability and Probable Founder Effect in Oculocutaneous Albinism Type 7.” Clinical Genetics, vol. 97, no. 3, Mar. 2020, pp. 527–28. EBSCOhost, https://doi.org/10.1111/cge.13655.

APA

Bataille, P., Michaud, V., Robert, M. P., Bekel, L., Leclerc-Mercier, S., Harroche, A., Célérier, C., Lasseaux, E., Borgel, D., Bremond-Gignac, D., Bodemer, C., Arveiler, B., & Hadj-Rabia, S. (2020). Clinical variability and probable founder effect in oculocutaneous albinism type 7. Clinical Genetics, 97(3), 527–528. https://doi.org/10.1111/cge.13655

Chicago

Bataille, Pauline, Vincent Michaud, Matthieu P Robert, Lilia Bekel, Stéphanie Leclerc-Mercier, Annie Harroche, Charlotte Célérier, et al. 2020. “Clinical Variability and Probable Founder Effect in Oculocutaneous Albinism Type 7.” Clinical Genetics 97 (3): 527–28. doi:10.1111/cge.13655.